BEATW
HEALTHCAREHeartBeam Inc - Warrants (31/10/2026)
Live · NASDAQ · May 9, Close
What's Moving BEATW Today?
No stock-specific AI insight has been generated for BEATW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.08
Fundamentals
Trading
BEATW News
21 articles- HeartBeam (BEAT) Expands Concierge Cardiology Footprint With Atelier Health AgreementYahoo Finance·May 7, 2026
- HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge PracticeYahoo Finance·May 7, 2026
- HeartBeam (BEAT) Tackles Heart Disease With Next-Generation ECG SolutionsYahoo Finance·May 6, 2026
- HeartBeam (BEAT) to Host Q1 2026 Earnings Call and Provide Strategic UpdatesYahoo Finance·Apr 30, 2026
- HeartBeam to Host First Quarter 2026 Results Conference Call on Wednesday, May 13, 2026 at 4:30 p.m. Eastern TimeYahoo Finance·Apr 30, 2026
- HeartBeam (BEAT): 10 Best NASDAQ Growth Stocks to Buy and Hold ForeverYahoo Finance·Apr 24, 2026
- HeartBeam (BEAT) Collaborates to Advance Next-Gen ECG SolutionsYahoo Finance·Apr 24, 2026
- HeartBeam (BEAT) Closes $10M Public Offering to Advance Cardiac Technology CommercializationYahoo Finance·Apr 17, 2026
- HeartBeam Announces Closing of $10 Million Public Offering of Common StockYahoo Finance·Apr 16, 2026
- HeartBeam (BEAT) Launches Proposed Public Offering to Support Commercialization and AI InitiativesYahoo Finance·Apr 15, 2026
- HeartBeam Announces Pricing of $10 Million Public Offering of Common StockYahoo Finance·Apr 15, 2026
- HeartBeam Announces Proposed Public Offering of Common StockYahoo Finance·Apr 14, 2026
- How Decentralized AI is Unlocking Value in Cardiac DiagnosticsBenzinga·Mar 27, 2026
- HeartBeam (BEAT) Partners With Mount Sinai to Accelerate AI-ECG Development and ValidationYahoo Finance·Mar 25, 2026
- HeartBeam (BEAT) Showcased for Advancing Innovative ECG PlatformYahoo Finance·Feb 20, 2026
- HeartBeam (BEAT) Reports Q3 2025 Results as FDA Review Nears Completion and Commercial Readiness AcceleratesYahoo Finance·Nov 14, 2025
- HeartBeam Inc (BEAT) Q3 2025 Earnings Call Highlights: Innovations and Challenges in Cardiac CareYahoo Finance·Nov 14, 2025
- HeartBeam Reports Third Quarter 2025 ResultsYahoo Finance·Nov 13, 2025
- HeartBeam (BEAT) Recognized as a Top Global Innovator in Portable ECG TechnologyYahoo Finance·Nov 12, 2025
- HeartBeam (BEAT) Schedules Third Quarter 2025 Conference Call for November 13Yahoo Finance·Oct 30, 2025
- HeartBeam to Host Third Quarter 2025 Results Conference Call on Thursday, November 13, 2025 at 4:30 p.m. Eastern TimeYahoo Finance·Oct 30, 2025
All 21 articles loaded
Price Data
52-Week Range
$0.08
Fundamentals
Trading
About HeartBeam Inc - Warrants (31/10/2026)
Heartbeam Inc. Warrant (BEATW) offers a unique investment prospect linked to Heartbeam Inc., a pioneering healthcare technology firm dedicated to revolutionizing cardiac diagnostics via advanced artificial intelligence and digital health solutions. The company's innovative platform aims to increase the accuracy of myocardial infarction diagnoses, enabling timely and effective interventions that enhance patient care. As the demand for remote monitoring and telehealth services in cardiovascular health continues to rise, Heartbeam Inc. is strategically positioned to leverage this growth, making BEATW an appealing option for institutional investors interested in impactful and forward-thinking medical technologies.